- US-listed companies
- Tanke Biosciences Corp
- Income statement
Tanke Biosciences Corp (TNBI) Income statement
Market cap
$536.96K
P/E ratio
1x
| 2011/12 | 2012/12 | |
| Revenue | 24 | 29 |
| Revenue growth (%) | - | |
| Cost of revenue | 15 | 19 |
| Gross profit | 9 | 10 |
| Gross margin (%) | ||
| Operating margin (%) | ||
| Operating income | 2 | 5 |
| Income before tax | -2,454,773 | 602,591 |
| Pretax margin (%) | -10.3 | 2.1 |
| Provision for income taxes | 681,321 | 831,597 |
| Effective tax rate (%) | ||
| Net income | -3,136,094 | -210,247 |
| Net income margin (%) | ||
| Earnings per share | -0.24 | - |
| Diluted EPS | -0.24 | - |
| EBITDA | ||
| EBITDA margin (%) |